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Abstract
Background: In 1996 the guideline 'The Red Eye' was first published by the Dutch College of
General Practitioners. The extent to which general practitioners adhere to this guideline is unclear.
Recently, data on the management of infectious conjunctivitis by general practitioners became
available from the Second Dutch National Survey of General Practice. We measured the age-
specific incidence of infectious conjunctivitis, described its management by Dutch general
practitioners, and then compared these findings with the recommendations made in the guideline.
Methods: In 2001, over a 12-month period, data from all patient contacts with 195 general
practitioners were taken from electronic medical records. Registration was episode-oriented; all
consultations dealing with the same health problem were grouped into disease episodes. Data
concerning all episodes of infectious conjunctivitis (ICPC-code F70 and sub codes) were analysed.
Results: Over one year, 5,213 new and recurrent episodes of infectious conjunctivitis were
presented to general practitioners from a population of N = 375,899, resulting in an overall
incidence rate of 13.9 per 1000 person-years, varying from more than 80/1000 py in children up to
one-year old, to less than 12/1000 py in children over the age of 4. Topical ophthalmic ointments
were prescribed in 87% of the episodes, of which 80% was antibiotic treatment. Fusidic acid gel was
most frequently prescribed (69%). In most episodes general practitioners did not adhere to the
guideline.
Conclusion: In 2001, the management of infectious conjunctivitis by Dutch general practitioners
was not in accordance with the recommendations of the consensus-based guideline published five
years previously, despite its wide distribution. In 2006 this guideline was revised. Its successful
implementation requires more than distribution alone. Probably the most effective way to achieve
this is by following a model for systemic implementation.
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Background
The guideline entitled 'The Red Eye' was first published by
the Dutch College of General Practitioners in 1996 [1].
The chapter concerning the management of infectious
conjunctivitis recommends that, when infectious con-
junctivitis is diagnosed, the general practitioner should
emphasize to the patient that it is a contagious, but harm-
less disorder, which normally gets better on its own. Fur-
thermore, the general practitioner should emphasize that
if bacterial involvement is suggested by purulent secre-
tion, antibiotic treatment might accelerate recovery. In
that case, the general practitioner should ask the patient if
they would prefer antibiotic treatment. In all other cases,
regular cleaning of the infected eye with water is advised.
Finally, the first and second choice antibiotics advised by
the guideline are chloramphenicol and tetracycline. In
1996 there was no evidence from primary care-based trials
on the treatment of infectious conjunctivitis. Hence, rec-
ommendations in the guideline were based upon consen-
sus and secondary care-based trials [2]. Data on the
management of infectious conjunctivitis in general prac-
tice from registration projects and studies, which took
place before the guideline was published, were available
[3-7]. These data showed that in more than 80% of cases
of acute infectious conjunctivitis general practitioners pre-
scribed ocular antibiotics. An interesting question is to
what extent general practitioners have adhered to the
guideline since its publication. The guidelines developed
by the Dutch College of General Practitioners are norma-
tive and form an accepted base for daily clinical prac-
tice[2,8]. Furthermore, a large part of the curriculum of
general practitioner trainees in the Netherlands is based
upon these guidelines, as are continuing-education
courses for general practitioners. Adherence to guidelines
is reinforced when recommendations are more evidence-
based, less controversial, and do not require changes in
practice [9]. Recently, new data on the management of
infectious conjunctivitis by general practitioners were
made available by the Second Dutch National Survey of
General Practice. This survey took place in 2001, five years
after the introduction of the guideline [10]. It contains
data from electronic medical records including diagnoses,
prescribed medication and referrals to secondary care.
Data from the survey provide insight into the manage-
ment of infectious conjunctivitis in daily clinical practice.
In this study we describe the age-specific incidence of clin-
ically diagnosed infectious conjunctivitis and its manage-
ment by general practitioners. These findings were then
compared with the recommendations made in the guide-
line.
Methods
Dutch National Survey of General Practice
The study took place within the framework of the Second
Dutch National Survey of General Practice, which was car-
ried out in 2001 by the Netherlands Institute for Health
Services Research (NIVEL) in collaboration with the
National Information Network of General Practice
(LINH). It included 61 general practices participating in
the LINH network, and 43 additional general practices
especially recruited for this survey. Thus, 104 general prac-
tices participated, with a total of 195 (164.75 FTE) general
practitioners, and about 390,000 patients. This sample
constitutes a representative group of Dutch primary care
physicians (age, sex, geographical region, and urbanisa-
tion level of practice location), with a slight under-repre-
sentation of single-handed general practitioners. All
participating practices were computerised, had electronic
patient files, and an electronic prescription system used
for diagnosis-related prescribing. Data were extracted
from all electronic medical records from each participat-
ing practice over a period of one year (mainly the calendar
year 2001). Study design and methods of the survey have
been published in more detail elsewhere[10].
Infectious conjunctivitis
Data about all patient contacts included information on
diagnosis, referrals, and prescriptions. Diagnoses were
coded according to the International Classification of Pri-
mary Care (ICPC). A contact was defined as a face-to-face
consultation of the patient with a general practitioner;
contacts by telephone and contacts between patients and
the medical receptionist were registered as a contact only
if they led to a prescription or a referral. The registration
was episode-oriented; all consultations dealing with the
same health problem were grouped into disease episodes.
The participating general practitioner decided whether a
contact belonged to an existing disease episode or was the
beginning of a new episode. A disease episode was coded
by the diagnosis made at the most recent contact of that
episode. Data on all episodes of infectious conjunctivitis
(ICPC-code F70 and sub codes), age and sex of the
patient, season, number of contacts with the general prac-
titioner, prescriptions and referrals, were extracted.
Analysis
The incidence of infectious conjunctivitis is represented as
an incidence rate (per 1000 person-years). The numerator
concerns new and recurrent episodes. A recurrent episode
is a second (or even third or more) isolated episode of
infectious conjunctivitis in the same patient within the
one-year registration period. The denominator concerns
the mid-time population size based upon the size and
composition of the population at the start and at the end
of the one-year registration period. The sex-specific inci-
dence rate differences in age groups (overall, age 0–14,
and 15 years and older) were calculated to investigate any
difference between incidence rates in men and women in
each age group. The season-specific incidence rate differ-
ence, spring and summer (from April to September) ver-BMC Family Practice 2007, 8:54 http://www.biomedcentral.com/1471-2296/8/54
Page 3 of 7
(page number not for citation purposes)
sus autumn and winter (from October to March), was also
calculated.
The Poisson distribution was used to calculate the 95%
confidence intervals of the incidence rates. Statistical anal-
yses were performed using SPSS (version 11.5.2). We used
Stata (version 9.1) to calculate the incidence rates and rate
differences and their 95% confidence intervals.
Results
Incidence rates
In a one-year period, 5,213 new and recurrent episodes of
infectious conjunctivitis were registered in a mid-time
population of N = 375,899. The patients were representa-
tive of the general population in terms of age, sex and type
of health care insurance (public/private). The incidence
rate of infectious conjunctivitis was 13.9 episodes per
1000 person-years (95% CI: 12.5 to 15.3). The majority of
the patients (96.1%) had one episode, 3.6% had two epi-
sodes, and 0.3% had three or more episodes of infectious
conjunctivitis within one year. Table 1 shows the inci-
dence rates of other conditions related to infectious con-
junctivitis. The incidence rate indicates that, in a standard
Dutch practice of 2350 patients, on average 32 (95% CI:
29 to 36) episodes of infectious conjunctivitis are
recorded each year. This indicates that infectious conjunc-
tivitis is ranked fifteenth in the list of most frequently seen
diseases in primary care.
Age, sex and seasonal relationships
Figure 1 shows that the incidence rate of infectious con-
junctivitis in young children and patients aged over 65
was high compared to other age groups. Children up to 11
years of age accounted for almost 25% of all episodes.
More episodes were recorded in women (14.9 per 1000
person-years) than in men (12.9 per 1000 person-years),
incidence rate difference: 2.0 episodes per 1000 person-
years (95% CI: 1.2 to 2.7). It seems that this difference is
mostly caused by the difference in incidence of infectious
conjunctivitis in adult women compared to men; the sex-
specific incidence rate difference in the age group 15 years
and older was 2.7 episodes per 1000 person-years (95%
CI: 1.9 to 3.4). The sex-specific incidence rate difference in
the age group 0 to 14 years was 0.4 episodes per 1000 per-
son-years (95%CI: -1.8 to 2.6). We found no evidence of
any seasonal influence on the incidence rate of infectious
conjunctivitis (data not shown).
Registration
Sixty-eight percent of the first contacts in an episode were
registered as "infectious conjunctivitis", 26% as bacterial
conjunctivitis and 6% as viral conjunctivitis. Most epi-
sodes (87%) consisted of one registered contact between
patient and general practitioner.
Management
General practitioners prescribed a topical ophthalmic
ointment to almost 87% of the patients with infectious
conjunctivitis, 80% of which was antibiotic treatment
(Figure 2). Fusidic acid gel was the most frequently pre-
scribed of these (69%), followed by chloramphenicol
(21%) (Figure 3). Surprisingly, 5% of all prescriptions
consisted of ointments containing corticosteroids. (Figure
2).
Of all patients with one or more episodes of infectious
conjunctivitis, 1.9% (n = 121) were referred to secondary
care with a referral diagnosis 'infectious conjunctivitis'. Of
these patients, 85% were referred to an ophthalmologist.
There was no difference in referral rate per 1000 episodes
in women compared to men, referral rate difference: 3.4
(95%CI: -5.1 to 11.8). Most referrals took place in the 25–
44 year and 45–64 year age groups, 29% and 29% respec-
tively.
Adherence to the guideline
These results show that in most episodes of infectious
conjunctivitis general practitioners do not adhere to the
guideline. In 21% of episodes, general practitioners regis-
tered bacterial conjunctivitis in the electronic medical
record. However, in more than two-thirds of all episodes
general practitioners prescribed a topical antibiotic. Fur-
thermore, fusidic acid was by far the most frequently pre-
scribed antibiotic, which differs from the first choice
antibiotic in the guideline.
Table 1: Incidence rates of other conditions in relation to infectious conjunctivitis
ICPC-code Condition Incidence rate
F70 Infectious conjunctivitis 13,9
F72 Blepharitis, Hordeolum, and Chalazion 5,6
F71 Allergic conjunctivitis 3,3
F75 Foreign body 3,1
F02 Red eye 2,1
F03 Discharge 1,6
F73 Other infection eye 1,4
F85 Cornela ulcera 0,8BMC Family Practice 2007, 8:54 http://www.biomedcentral.com/1471-2296/8/54
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Age-specific incidence rates of infectious conjunctivitis (episodes per 1000 py) Figure 1
Age-specific incidence rates of infectious conjunctivitis (episodes per 1000 py).
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Conclusion
Summary of main findings
The results show that, in 2001, five years after the publica-
tion of the guideline, the management of infectious con-
junctivitis by general practitioners was predominantly not
according to the guideline. Patients with infectious con-
junctivitis received antibiotic treatment in almost 70% of
episodes making the total number of prescriptions for
antibiotics by general practitioners remarkably high. It is
in contrast with the guideline's recommendations to limit
the prescription of antibiotics to those patients with sus-
pected bacterial involvement [1]. Although the guideline
recommends chloramphenicol as the antibiotic of first
choice, fusidic acid gel was by far most frequently pre-
scribed. The data also show that almost all Dutch patients
with an infectious conjunctivitis are managed in primary
care.
The contrast between the guideline and daily practice may
be explained as follows. The advice on treatment in the
guideline was not based on randomised trials in patients
typical of those seen in primary care, and therefore publi-
cations on this subject might not have caught the atten-
tion of general practitioners. Assumptions made in the
guideline on the symptoms indicative of a diagnosis of
infectious conjunctivitis, bacterial conjunctivitis in partic-
ular, were based on consensus. In a literature search we
found no evidence to back up these assumptions [11].
Furthermore, consultations for conjunctivitis are often
seen as a "catch up consultation" [12]. It is easier and less
time consuming to give the patient the prescription they
expect than to explain why a prescription is not necessary.
Another reason is the preference or the expectation of the
patient to be treated with an antibiotic. A British qualita-
tive study, investigating why general practitioners pre-
scribe antibiotics for infectious conjunctivitis in children,
showed that the majority of parents of these children felt
that treatment would help their child get better more
quickly and most felt this treatment should be sought
immediately. Furthermore, more than half of the parents
felt that their child would not get better unless treated
[12]. Finally, many day care centres and schools do not re-
admit children before they have consulted their doctor,
have been treated with antibiotics, or even until they are
better. It should be noticed that this policy by day care
centres and schools is in contradiction with recommenda-
tions made by Dutch municipal health services guidelines
[13]. According to these guidelines, children with infec-
tious conjunctivitis are not to be excluded from day care
centres or school.
Surprisingly, 5% of all prescribed treatments contained
corticosteroids, with or without antibiotics. It should be
emphasised that this treatment for infective conjunctivitis
Choice of topical ophthalmic antibiotic; distribution across different antibiotics Figure 3
Choice of topical ophthalmic antibiotic; distribution across different antibiotics.
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is not recommended by our guidelines, and the general
opinion is that corticosteroid prescriptions should only be
initiated by ophthalmologists, after careful evaluation.
The reasons for general practitioners to prescribe corticos-
teroids cannot be evaluated within our data. Possibly
these prescriptions were repeat prescriptions first issued
by ophthalmologists.
Strengths and limitations of the study
The strength of this study is that the results can be extrap-
olated to the general Dutch population and Dutch general
practitioners and probably also to other Western Euro-
pean countries. The population and general practices
studied are representative of the Dutch situation. Further-
more, a Dutch study has shown that no differences exist in
working style between those general practitioners who
participated in a registration network and those who did
not. This also holds for general practitioners working in
computerised or non-computerised practices [14]. How-
ever, it should be noted that the survey contained a rela-
tively low number of single-handed general practitioners.
A limitation of this study might be the fact that the data
extraction was focused on ICPC-code F70 and sub codes
only, as coded on the diagnostic line in the Electronic
Medical Record. This means that our findings depend
strongly on the quality of registration by the general prac-
titioners. However, participating general practitioners
were trained and experienced users of electronic medical
records and ICPC. They did not differ from other general
practitioners in diagnosing disease episodes [15]. Inter-
doctor variation in ICPC coding of participating general
practitioners was small and the level of agreement with
external ICPC experts (n = 4) was on average 81% [15].
Another limitation might be the fact that only face-to-face
consultations were registered. Contacts by telephone and
with the receptionist that did not lead to a well-defined
action were not registered. For example, a question from a
patient about a red eye which did not lead to any action
by the general practitioner or receptionist would have
been missed. Therefore, there might be some under-repre-
sentation of cases of infectious conjunctivitis in which no
treatment was given. However, this proportion of patients
will be small. First, only 15% of all contacts were tele-
phone contacts [16]. Second, most telephone contacts
about infectious conjunctivitis will either lead to a pre-
scription or advice.
Comparison with existing literature
Over two-thirds of the episodes of infectious conjunctivi-
tis were treated with topical antibiotics, almost seventy
percent of those with fusidic acid. Although not compara-
ble to the Second Dutch National Survey of General Prac-
tice, an English study performed in January 2001 indicates
that the total number of prescriptions by English general
practitioners might even be higher. In this postal ques-
tionnaire survey on the management of acute infectious
conjunctivitis among of 303 general practitioners in
Southern England, 95% of the 234 responding general
practitioners indicated they usually prescribed topical
antibiotics for acute infectious conjunctivitis [17]. In fact,
in England, 3.4 million community prescriptions for top-
ical ocular antibiotics are issued each year, and in the
Netherlands more than 900,000 prescriptions for topical
ocular antibiotics were issued in 2001. Primary care phy-
sicians issued 85% of these prescriptions[18,19].
In 2003 in the United Kingdom, chloramphenicol and
fusidic acid gel were the first and the second most pre-
scribed topical ocular antibiotics. About 25% of all topical
ocular antibiotic prescriptions were for fusidic acid [19].
This is in line with the results from the survey by Everitt et
al., in which 13% (95%CI: 8–17) of the prescriptions con-
cerned fusidic acid gel, compared to 87% (95%CI: 83–92)
prescriptions of chloramphenicol [17].
The prescription policy of Dutch general practitioners
may be explained by the fact that fusidic acid gel needs to
be administered less frequently than chloramphenicol eye
drops, and also, it appears to have no serious adverse
effects [20].
After the guideline appeared, the results of two trials, con-
ducted in primary care were published, [21,22]. These
results backed up the recommendations on treatment
made in the guideline. In one of these trials we had com-
pared fusidic acid gel 1% to placebo in adult patients with
acute infectious conjunctivitis. We found that after seven
days, recovery rates in the fusidic acid gel and placebo
groups were essentially the same. Furthermore, 65% of
the 58 isolates found in 181 patients were resistant to
fusidic acid. The only pathogen not resistant to fusidic
acid was Staphylococcus aureus, accounting for 13 of the 58
isolates [21]. Rose et al. studied the effect of chloram-
phenicol treatment for acute infectious conjunctivitis in
children aged 6 months to 12 years compared to placebo
[22]. Their findings were essentially the same; most chil-
dren will get better by themselves equally quickly and thus
do not need antibiotic treatment.
Implications for clinical practice
The question is whether general practitioners should pre-
scribe antibiotics at all to patients with infectious con-
junctivitis. The prevalence of bacterial origin in our trial
was 32% [21]. In a similar population Everitt et al. found
a bacterial pathogen rate of 50%, whereas Rose et al.
found a bacterial pathogen rate of 78% in children
[22,23]. As these studies show, the spontaneous resolu-
tion rate of bacterial conjunctivitis is high. However, we
also found that in culture-positive patients the treatmentBMC Family Practice 2007, 8:54 http://www.biomedcentral.com/1471-2296/8/54
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effect tended to be strong [21]. Furthermore, a diagnostic
study by our group showed that it might be possible for
the general practitioner to identify bacterial origin of
infectious conjunctivitis by asking the patient three ques-
tions, namely about gluey eyes in the morning, itching,
and a history of infectious conjunctivitis [24]. Asking
these questions is a good way of identifying those patients
who have a bacterial infection and those who do not.
However, this diagnostic rule has not been validated yet.
Therefore, at this time, we must accept that it is difficult to
differentiate clinically between bacterial and viral con-
junctivitis. As shown by Everitt et al., no or a delayed pre-
scription is a safe strategy [23]. Following this policy will
help to reduce unnecessary prescription of antibiotics.
In 2006 the 'The Red Eye' guideline was revisited [25]. An
major part of the revision was based on the primary care
trials already referred to in this discussion [21,22]. Its suc-
cessful implementation requires more than distribution
alone. Probably the most effective way to achieve this is by
following a model for systemic implementation [26].
In conclusion, over two-thirds of episodes of infectious
conjunctivitis are treated with topical antibiotics, almost
seventy percent of these with fusidic acid. This is at odds
with the recommendations of the Red Eye guideline and
recently published evidence on this subject. If the patient
specifically wants antibiotics then they should only be
prescribed if there is a high probability of a bacterial ori-
gin.
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